Bigfoot Biomedical Gets $45 Million of Financing Led by Abbott Labs
January 13 2020 - 4:31PM
Dow Jones News
By Josh Beckerman
Abbott Laboratories (ABT) led $45 million of financing for
Bigfoot Biomedical, the initial tranche of a Series C round.
The funding also included Quadrant Capital Advisors, Senvest
Capital, Janus Henderson and Cormorant Asset Management.
Bigfoot is developing the Bigfoot Unity Diabetes Management
Program, an insulin dosing platform that integrates Abbott's
FreeStyle Libre glucose sensing technology.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
January 13, 2020 16:16 ET (21:16 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Sep 2023 to Sep 2024
